Partnership expanded to offer hands-on experiences in health care fields

Translate to Spanish or other 102 languages!

Mega Doctor News

- Advertisement -
UTRGV President Dr. Guy Bailey and members of his leadership team, recently toured the PSJA Dr. Daniel P. King College & University Center in San Juan as part of these efforts.
UTRGV President Dr. Guy Bailey and members of his leadership team, recently toured the PSJA Dr. Daniel P. King College & University Center in San Juan as part of these efforts. Courtesy Image

PHARR, Texas – As part of efforts to ensure students have the resources and experiences necessary to succeed, the Pharr-San Juan-Alamo ISD (PSJA ISD) School Board of Trustees recently signed three agreements to continue partnerships with the University of Texas Rio Grande Valley. 

The agreements with the School of Nursing Program, Educational Experience Affiliation, and College of Health Professions, will allow PSJA ISD and UTRGV to collaborate to create educational experiences for current university students and ultimately PSJA ISD students interested in health science careers. 

Courtesy Image

“We are very excited to formalize these agreements with the University of Texas Rio Grande Valley allowing us to continue to work together,” said PSJA Health Services Director Sulema Solis. “We hope these collaborations open up new opportunities for our students in the future.” 

- Advertisement -

As part of the agreements, PSJA ISD will be providing UTRGV personnel and university students supervised access to patients for practicum rotations. Through the collaboration, PSJA ISD hopes to expand opportunities for students interested in health science to be exposed to tours, orientations, and hands on workshops from UTRGV. 

UTRGV President Dr. Guy Bailey and members of his leadership team, recently toured the PSJA Dr. Daniel P. King College & University Center in San Juan as part of these efforts.

Courtesy Image

“Thank you to our School Board of Trustees for supporting these important efforts as we continue expanding our partnerships with higher education institutions, to ultimately provide our students with even more life-changing educational experiences,” said PSJA Superintendent Dr. Jorge L. Arredondo.  

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

FDA Approves First Drug of Its Kind for Polycythemia Vera, a Rare Blood Disorder

The U.S. Food and Drug Administration today approved Mimrylo (rusfertide), a new treatment for adults with polycythemia vera, a rare blood disorder that causes the body to make too many red blood cells.

FDA Approves First Oral Drug Indicated to Treat Dermatomyositis in Adults

Lisraya is the first FDA-approved oral treatment option for patients with dermatomyositis, addressing the high unmet need for this rare disease.

FDA Authorizes First Wearable Device that Continuously Monitors Both Ketone Levels and Blood Sugar

The U.S. Food and Drug Administration today authorized the Libre Duo 10 Day Continuous Dual Glucose Ketone Monitoring System for people aged 2 years and older living with diabetes.

STHS McAllen Launches Naming Contest for Advanced Surgical Robot

Using advanced robotic technology to assist surgeons in performing complex procedures with enhanced precision, dexterity and control, robotic surgery represents one of the most significant advancements in modern medicine.
- Advertisement -